FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lorazepam submitted by Hospira, Inc. under ANDA 074243.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Seizure Disorders

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)